Evidence map›Paper›PMID 39060924›Full record

GuidelineBMC pediatrics2024

Guideline for the diagnosis and treatment of incomplete Kawasaki disease in children in China.

Fuyong Jiao, Yan Pan, Zhongdong Du, Fangming Deng, Xiaodong Yang, Hong Wang, Jie Shen, Wei Xiang, Zhilong Mu, Chunyan Gao and 1 more

Abstract readPractice Guideline
PubMed Full text at PMC Publisher
In one paragraph

Guideline in BMC pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. [DeepSeek perspective on managing Kawasaki disease in Chinese children].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Fuyong JiaoChildren's Hospital, Shaanxi Provincial People's Hospital, Xian, 710000, China.
Yan PanDepartment of Pediatrics, the First Affiliated Hospital of Yangtze University, Jingzhou, 434000, China. woshipanyan@126.com.
Zhongdong DuNational Center for Children's Health, Beijing Children's Hospital, Capital Medical University, Beijing, 100000, China. zhongdong_du@163.com.
Fangming DengEditorial Department of Chinese Journal of Contemporary Pediatrics, Xiangya Hospital, Central South University, Changsha, 410000, China.
Xiaodong YangDepartment of Cardiology, Shanghai Children's Hospital, Shanghai Jiaotong University, Shanghai, 200120, China.
Hong WangDepartment of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, 110004, China.
Jie ShenDepartment of Cardiology, Shanghai Children's Medical Center, Shanghai Jiao Tong University, Shanghai, 200120, China.
Wei XiangHainan Women and Children's Medical Center, School of Pediatrics, Hainan Medical University, Haikou, 570100, China.
Zhilong MuChildren's Hospital, Shaanxi Provincial People's Hospital, Xian, 710000, China.
Chunyan GaoDepartment of Pediatrics, the Affiliated Hospital of Yan'an University, Yan'an, 716000, China.
Jinmei BaiDepartment of Pediatrics, the Affiliated Hospital of Yan'an University, Yan'an, 716000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKawasaki disease (KD) is a pyretic ailment predominantly observed in children aged below 5 years. There is currently a dearth of precise markers for timely identification of incomplete Kawasaki disease (IKD). It is imperative to develop updated, comprehensive, and evidence-based guidelines to effectively direct clinical practice.

methodsThe guideline development group comprised individuals with diverse expertise in both content and methodology and carried out an extensive exploration of the following digital repositories: CNKI, VIP, Wanfang Data, UpToDate, BMJ, Clinical Evidence, National Guideline Clearinghouse, Joanna Briggs Institute Library, Cochrane Library, and PubMed. The entire period from the establishment of these databases until January 1, 2024 was covered. To evaluate IKD, systematic reviews and randomised controlled trials were assessed using the risk of prejudice instrument specified in the Cochrane Handbook, along with the evidence robustness framework established by the GRADE group. The recommendations were formulated based on the findings, considering the evidence strength. After several iterations of expert consensus, the relevant professional committees in China endorsed the ultimate guideline.

resultsThese guidelines address clinical questions regarding the classification and definition of KD, diagnosis of IKD, treatment during the acute phase of IKD, and follow-up of IKD.

conclusionsTo provide healthcare professionals with guidance and decision-making bases for the diagnosis and treatment of IKD in China, 13 recommendations were formulated based on expert consensus and evidence of best practices.

Indexed as

Mucocutaneous Lymph Node SyndromeChildChild, PreschoolChinaHumansInfantClinical guidelineExpert panel’s guidelineExpert recommendationIncomplete Kawasaki diseaseRandomized controlled trials

Identifiers

PMID39060924
PMCPMC11282762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.